Published in Gene Therapy Weekly, December 28th, 2006
Covance's ICBP90 monoclonal antibody recognizes the DNA-binding protein ICBP90, a human protein involved in the regulation of topoisomerase II gene expression. Abnormal expression of ICBP90 has been observed in a variety of malignancies.
Estrogen receptor (ER) alpha has been extensively studied and identified as a growth mediator in the breast, and ER status has been used to determine response to chemotherapies. Covance's ER alpha clone D75 enables...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.